Pricing Log in Create free account

BRIACELL THERAP (BCTX) vs Cel-Sci Corporation (CVM)

BRIACELL THERAP and Cel-Sci Corporation are both Biotechnology companies. BRIACELL THERAP and Cel-Sci Corporation are of similar size ($32.8M and $30.6M). Cel-Sci Corporation has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.5×. Across the 10 metrics below, BRIACELL THERAP leads on 5 and Cel-Sci Corporation on 5.

Valuation

Metric BCTX CVM Biotechnology median
P/E 1.53 n/m 8.50
P/S n/m 38.82 9.71
P/B 1.06 1.98 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 35.01 9.21
Earnings yield 65.24% (63.81%) (33.15%)
Free cash flow yield (126.67%) (77.45%) (25.50%)

Profitability

Metric BCTX CVM Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (173.55%) (252.53%) (56.36%)
Return on assets (139.20%) (108.91%) (48.04%)
Return on invested capital (3,311.00%) (169.59%) 0.00%

Growth

Metric BCTX CVM Biotechnology median
Revenue growth (TTM) — 20.75% 6.02%
EPS growth (last fiscal year) (43.04%) 59.06% 30.26%
Revenue growth, 5-year CAGR — 16.18% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCTX CVM Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 7.07 1.48 4.72
Net debt to EBITDA 0.66 0.25 0.96

Dividend

Metric BCTX CVM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCTX CVM Biotechnology median
Market cap 32.76m 30.61m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack